Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hind Lal

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of Molecular and Cellular Cardiology|October 18, 2008
Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinasesHind Lal, Suresh K Verma, Honey B Golden, et al.
Basic Research in Cardiology|September 1, 2023
Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesisPrachi Umbarkar, Suma Ejantkar, Sulivette Y Ruiz Ramirez, et al.
Journal of Extracellular Biology|July 1, 2024
Bone marrow-fibroblast progenitor cell-derived small extracellular vesicles promote cardiac fibrosis via miR-21-5p and integrin subunit αV signallingPrabhat Ranjan, Roshan Kumar Dutta, Karen Colin, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 2, 2025
Fibroblast-specific MyD88-dependent signaling aggravates inflammation and cardiac dysfunction in the MI heartPrachi Umbarkar, Sultan Tousif, Ashish Jaiswal, et al.
Circulation|November 17, 2011
Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and deathHind Lal, Jibin Zhou, Firdos Ahmad, et al.
Circulation Research|September 2, 2022
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured HeartPrachi Umbarkar, Sultan Tousif, Anand P Singh, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2007
Integrins: novel therapeutic targets for cardiovascular diseasesHind Lal, Rakeshwar S Guleria, Donald M Foster, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarctionLan Wu, Rajeev Dalal, Connie D Cao, et al.
Circulation Research|January 10, 2023
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated InflammationSultan Tousif, Anand P Singh, Prachi Umbarkar, et al.
Journal of the American College of Cardiology|August 16, 2014
Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failureFirdos Ahmad, Hind Lal, Jibin Zhou, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of Molecular and Cellular Cardiology|October 18, 2008
Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinasesHind Lal, Suresh K Verma, Honey B Golden, et al.
Basic Research in Cardiology|September 1, 2023
Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesisPrachi Umbarkar, Suma Ejantkar, Sulivette Y Ruiz Ramirez, et al.
Journal of Extracellular Biology|July 1, 2024
Bone marrow-fibroblast progenitor cell-derived small extracellular vesicles promote cardiac fibrosis via miR-21-5p and integrin subunit αV signallingPrabhat Ranjan, Roshan Kumar Dutta, Karen Colin, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 2, 2025
Fibroblast-specific MyD88-dependent signaling aggravates inflammation and cardiac dysfunction in the MI heartPrachi Umbarkar, Sultan Tousif, Ashish Jaiswal, et al.
Circulation|November 17, 2011
Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and deathHind Lal, Jibin Zhou, Firdos Ahmad, et al.
Circulation Research|September 2, 2022
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured HeartPrachi Umbarkar, Sultan Tousif, Anand P Singh, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2007
Integrins: novel therapeutic targets for cardiovascular diseasesHind Lal, Rakeshwar S Guleria, Donald M Foster, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarctionLan Wu, Rajeev Dalal, Connie D Cao, et al.
Circulation Research|January 10, 2023
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated InflammationSultan Tousif, Anand P Singh, Prachi Umbarkar, et al.
Journal of the American College of Cardiology|August 16, 2014
Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failureFirdos Ahmad, Hind Lal, Jibin Zhou, et al.
Pageof 7